Literature DB >> 3764651

Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis.

J Jääskeläinen.   

Abstract

From 1953 to 1980, 657 patients survived a seemingly complete removal of a histologically benign intracranial meningioma. Recurrence of the tumor was found in 59 of these 657 patients, but some cases of recurrence may have been missed inasmuch as only 69 patients were followed for 20 years. With ordinary life-table analysis, the overall recurrence rate was estimated to be 19% at 20 years. The reliability of this result was evaluated with a modified life-table analysis. Multivariate analysis showed that coagulation of the dural insertion, invasion of bone, and soft consistency of tumor were strong risk factors (p less than 0.01) for recurrence. The recurrence rate at 20 years was estimated to be 11% for the 249 patients with none of these risk factors, 15-24% for those with one factor, and 34-56% for those with two.

Entities:  

Mesh:

Year:  1986        PMID: 3764651     DOI: 10.1016/0090-3019(86)90259-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  90 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.

Authors:  Therese A Dolecek; Emily Van Meter Dressler; Jigisha P Thakkar; Meng Liu; Abeer Al-Qaisi; John L Villano
Journal:  Cancer       Date:  2015-04-14       Impact factor: 6.860

4.  Factors influencing meningioma recurrence rate.

Authors:  M Naumann; J Meixensberger
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

6.  Salvage chemotherapy with CPT-11 for recurrent meningioma.

Authors:  Marc C Chamberlain; Denice D Tsao-Wei; Susan Groshen
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 7.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

8.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  [Sphenoorbital meningiomas: results in long-term treatment].

Authors:  U Schick
Journal:  HNO       Date:  2010-01       Impact factor: 1.284

10.  Intracranial meningiomas. Analysis of 344 surgically treated cases.

Authors:  N Altinörs; L Gürses; N Arda; A Türker; E Senveli; T Dönmez; M Sanli; M Bavbek; H Caner
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.